અમદાવાદ, 13 નવેમ્બર

Q2FY24 EARNING CALENDAR 13.11.2023: GRASIM, GSS, GUJPETR, LAMBODHARA,MANAPPURAM, NARAYANA HRUDAYALAYA, NRBBEARING

GRASIM

• Revenue expected at Rs 6181 crore versus Rs 6745 crore

• EBITDA expected to be seen at Rs 636 crore versus Rs 956 crore

• EBITDA margin expected to be seen at 10.3% versus 19.4%

• Net profit expected to be seen at Rs 760 crore versus of Rs 1052 crore

MANAPPURAM

• Revenue expected at Rs 1327 crore versus Rs 1079 crore

• EBIT expected to be seen at Rs 804 crore versus Rs 633 crore

• EBIT margin expected to be seen at 60.6% versus 58.6%

• Net profit expected to be seen at Rs 513 crore versus of Rs 408 crore

HRUDAYALAYA

• Revenue expected at Rs 1281 crore versus Rs 1141 crore

• EBITDA expected to be seen at Rs 285 crore versus Rs 274 crore

• EBITDA margin expected to be seen at 22.2% versus 24.0%

• Net profit expected to be seen at Rs 173 crore versus of Rs 168 crore

Q2FY24 EARNING CALENDAR 14.11.2023: ACCEL, ASTRAMICRO, CAPACITE, CONCORD, DCMSRMIND, IBULHSGFIN, IMPEXFERRO, ISGEC, JINDALPOLY, KDDL, LAOPALA, KNRCON, LAOPALA, MAITHANALL, MCLEODRUSS, NATCOPHARM, NMDC, NFL, ORISSAMINE, PCJEWELLER, RAJESHEXPO, SIGACHI, SML, SOLARA, TRIDENT, WOCKPHARMA, YATRA

બિઝનેસ ગુજરાત વેબસાઈટમાં આવતાં news updates મેળવવા માટે નીચેની લિંક ઉપર ક્લિક કરી ફોલો કરો

https://whatsapp.com/channel/0029VaDvQgaDOQIYqUTAu20r

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)